@prefix ns0: <http://rdf-vocabulary.ddialliance.org/xkos#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<http://www.irandoc.acir/onto/irandoc/CHEBI:138839> ns0:has_role <http://www.irandoc.acir/onto/irandoc/CHEBI:77108> .
ns0:synonym_RELATED rdfs:label "مترادف مرتبط"@fa, "synonym RELATED"@en .
ns0:subset rdfs:label "زیرمجموعه"@fa, "subset"@en .
<http://www.irandoc.acir/onto/irandoc/CHEBI:76835>
  skos:prefLabel "ec 1.1.1.* (oxidoreductase acting on donor ch-oh group, nad(+) or nadp(+) acceptor) inhibitor"@en, "مهارکننده EC 1.1.1.* (اکسیدوردوکتاز که بر روی گروه CH OH دهنده، گیرنده NAD(+) یا NADP(+) اثر می گذارد)"@fa ;
  a <http://www.irandoc.ac.ir/onto/irandoc-meta/Concept>, skos:Concept ;
  skos:narrower <http://www.irandoc.acir/onto/irandoc/CHEBI:77108> .

<http://www.irandoc.acir/onto/irandoc/CHEBI:77108>
  ns0:synonym_RELATED "11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor", "PGDH inhibitor", "NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors", "EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitors", "15-hydroxyprostaglandin dehydrogenase inhibitors", "PGDH inhibitors", "15-OH-PGDH inhibitor", "prostaglandin dehydrogenase inhibitor", "15-hydroxyprostanoic dehydrogenase inhibitors", "15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitor", "NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor", "15-hydroxyprostanoic dehydrogenase inhibitor", "EC 1.1.1.141 inhibitors", "(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor", "15-hydroxyprostaglandin dehydrogenase inhibitor", "(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors", "11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors", "(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor", "15-OH-PGDH inhibitors", "(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitors", "15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitor", "15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitors", "EC 1.1.1.141 inhibitor", "NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor", "prostaglandin dehydrogenase inhibitors", "15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitors", "NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors" ;
  skos:prefLabel "مهارکننده EC 1.1.1.141 [15 هیدروکسی پروستاگلاندین دهیدروژناز (NAD(+))]"@fa, "ec 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (nad(+))] inhibitor"@en ;
  skos:broader <http://www.irandoc.acir/onto/irandoc/CHEBI:76835> ;
  ns0:subset "3_STAR" ;
  a <http://www.irandoc.ac.ir/onto/irandoc-meta/Concept>, skos:Concept .

